The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

A groundbreaking new study reveals a gene-editing therapy that dramatically lowered 'bad' cholesterol in monkeys, offering ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

Following the weekend data presentation, Citizens voiced optimism regarding CRISPR’s in-vivo projects. The firm noted some ...

Key breakthrough for the return of the dodo: viable cells have been obtained and genetically modified birds have been prepared.

The Minister noted that with the development and transfer of India's first indigenous CRISPR-based gene therapy, the nation ...

New research breaks down how scientists use CRISPR technology to lower cholesterol. The cholesterol-lowering effects could be permanent.

Oppenheimer emphasized the advancements in CRISPR’s in vivo initiatives, highlighting the comprehensive findings from the ...

Nearly 40% of respondents identified AI-based frameworks as their top priority for reducing cyber risk over the next three ...